Comment from Center for Biological Diversity
AnonymousOpposeAdvocacy
Summary: The Center for Biological Diversity opposes the citizen petition seeking to restrict the FDA's regulation of mifepristone. They argue that the petition lacks legal and factual basis, misrepresents environmental laws, and relies on ideology rather than scientific evidence regarding water contamination and endangered species.
See attached file(s)